The number of hydroxychloroquine prescriptions by specialists who don’t typically prescribe the drug skyrocketed after preliminary reports in March suggested potential benefits for patients with coronavirus disease 2019 (COVID-19).
CDC investigators analyzed hydroxychloroquine and chloroquine prescriptions dispensed by US retail pharmacies from January through June 2019 and during the same period in 2020. Prior to 2020, the drugs were prescribed most often by primary care physicians or specialists like rheumatologists or dermatologists for autoimmune disorders or as malaria prophylaxis.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
However, the analysis showed that prescriptions written by specialists who don’t typically use the drugs rose to 75 569 in March 2020 from 1143 in February 2020—an 80-fold increase compared with March 2019. Among specialists who don’t routinely prescribe hydroxychloroquine and chloroquine, the greatest growth in outpatient prescriptions in March 2020 was in the fields of ophthalmology, anesthesiology, and cardiology.
You currently have no searches saved.
You currently have no courses saved.